Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3065840 | 0.86 | SRC (0.43) | SRCL3MBTL1TDP1CYP2C9CYP2C19 | |
| SCHEMBL30451960 | 0.82 | SRC (0.50) | SRCL3MBTL1TDP1CYP2C9CYP2C19 | |
| SCHEMBL11768711 | 0.80 | L3MBTL1 (0.47) | SRCL3MBTL1TDP1CYP2C9CYP2C19 | |
| SCHEMBL9634847 | 0.80 | L3MBTL1 (0.50) | SRCL3MBTL1TDP1CYP2C9CYP2C19 | |
| SCHEMBL9361077 | 0.79 | MEN1 (0.48) | TDP1CYP2C9CYP2C19MEN1KMT2A | |
| SCHEMBL16163141 | 0.77 | SRC (0.40) | SRCL3MBTL1TDP1CYP2C9CYP2C19 | |
| SCHEMBL3401427 | 0.76 | SRC (0.60) | SRCL3MBTL1TDP1CYP2C9CYP2C19 | |
| SCHEMBL3490037 | 0.76 | SRC (0.54) | SRCL3MBTL1TDP1CYP2C9CYP2C19 | |
| SCHEMBL10965332 | 0.76 | SRC (0.43) | SRCL3MBTL1TDP1CYP2C9CYP2C19 | |
| SCHEMBL28911324 | 0.76 | SRC (0.43) | SRCL3MBTL1TDP1CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118292297-B | Washable flame retardant applied to filter material and application method thereof | 东莞市三威新材料科技有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118292297-A | Washable flame retardant applied to filter material and application method thereof | 东莞市三威新材料科技有限公司 | 2024-07-05 | — | — | CN | claimed |
| US-10053483-B2 | Synthesis process of antiparasitic drug selamectin | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2018-08-21 | — | — | US | claimed |
| EP-2835376-B1 | NEW SYNTHESIS PROCESS OF ANTIPARASITIC DRUG SELAMECTIN | ZHEJIANG HISUN PHARM CO LTD (CN) | 2018-05-02 | — | — | EP | claimed |
| US-20150329581-A1 | NEW SYNTHESIS PROCESS OF ANTIPARASITIC DRUG SELAMECTIN | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2015-11-19 | — | — | US | claimed |
| EP-2835376-A1 | NEW SYNTHESIS PROCESS OF ANTIPARASITIC DRUG SELAMECTIN | Zhejiang Hisun Pharmaceutical Co. Ltd. (CN) | 2015-02-11 | — | — | EP | claimed |
| CN-118292297-B | Washable flame retardant applied to filter material and application method thereof | 东莞市三威新材料科技有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118292297-B | Washable flame retardant applied to filter material and application method thereof | 东莞市三威新材料科技有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-118292297-A | Washable flame retardant applied to filter material and application method thereof | 东莞市三威新材料科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-118292297-A | Washable flame retardant applied to filter material and application method thereof | 东莞市三威新材料科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| US-10053483-B2 | Synthesis process of antiparasitic drug selamectin | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2018-08-21 | — | — | US | disclosed |
| EP-2835376-B1 | NEW SYNTHESIS PROCESS OF ANTIPARASITIC DRUG SELAMECTIN | ZHEJIANG HISUN PHARM CO LTD (CN) | 2018-05-02 | — | — | EP | disclosed |
| EP-2984097-B1 | HIGHLY ACTIVE NUCLEOSIDE DERIVATIVE FOR THE TREATMENT OF HCV | ACHILLION PHARMACEUTICALS INC (US) | 2017-03-29 | — | — | EP | disclosed |
| US-20140066398-A1 | HCV POLYMERASE INHIBITORS | MEDIVIR, AB (SE) | 2014-03-06 | — | — | US | disclosed |
| WO-2013084165-A1 | HCV POLYMERASE INHIBITORS | MEDIVIR AB (SE) | 2013-06-13 | — | — | WO | disclosed |
| US-20130143835-A1 | HCV Polymerase Inhibitors | MEDIVIR AB (SE) | 2013-06-06 | — | — | US | disclosed |
| CN-101302327-B | Halogen-free fire-resistant epoxy resin composition, film and copper clad laminate | GUANGKE INDUSTRY CORP | 2011-05-04 | — | — | CN | disclosed |
| CN-101302327-A | Halogen-free fire-resistant epoxy resin composition, film and copper clad laminate | GUANGKE INDUSTRY CORP (CN) | 2008-11-12 | — | — | CN | disclosed |
| EP-0409227-A2 | Pyrimidine nucleosides, their preparation and pharmaceutical preparations | MATTHES, Eckart, Dr. (DE) | 1991-01-23 | — | — | EP | disclosed |
| EP-0151554-A1 | Derivatives of phenylsulfonamides | CIBA-GEIGY AG (CH) | 1985-08-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130143835-A1 | HCV Polymerase Inhibitors | POLI, HAVCR2, EIF2AK2 | SRC 3480/4885L3MBTL1 4104/4885TDP1 3516/4885 |
| US-10053483-B2 | Synthesis process of antiparasitic drug selamectin | ODC1, DHPS, SELP | SRC 4526/4885L3MBTL1 3899/4885TDP1 3937/4885 |
| US-20150329581-A1 | NEW SYNTHESIS PROCESS OF ANTIPARASITIC DRUG SELAMECTIN | ODC1, DHPS, AOC1 | SRC 4464/4885L3MBTL1 4097/4885TDP1 3806/4885 |
| US-20140066398-A1 | HCV POLYMERASE INHIBITORS | POLI, HAVCR2, EIF2AK2 | SRC 3480/4885L3MBTL1 4104/4885TDP1 3516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.